This award celebrates great work going on within pharmaceutical, biopharma, biotech and other healthcare companies. The Award is open to any multi-disciplinary in-house team focussed on driving health communications/medical affairs.
The award recognises that in-house teams may be managing programmes around both internal and external challenges and opportunities and engaging audiences within and outside their organisation.
Healthcare consultancies may also submit an entry on behalf of a client in-house team providing the relevant authorisations are completed.
Entries must include a print quality colour photograph of the team and state the number of people in the team.
2024 PROCESS:
There will be two stages for this award:
- Stage 1 will consist of a written entry, which should be completed using the criteria below. The written entry does not include any marks for an oral presentation, as this will be judged separately from the written presentation. The judges will review the written entries in Stage 1 and those teams whose written entries have been shortlisted will be invited to present to the judging panel during Stage 2.
- Stage 2 will consist of a live presentation to the judging panel, as previously for this category on Friday 17 May 2024. Stage 1 scores will not be carried forward into Stage 2. The shortlisted team will be required to give a short presentation on their entry and will then be asked questions by the judges relating to their team performance. The judges will select the award winner based on this presentation, and the extent to which it supports and validates the original written entry.
The organisers will send invitations by 3 May 2024, therefore it is advisable for up to four members of your team to hold the 17 May 2024 open.